TVTX
Travere Therapeutics Inc.
Latest News for TVTX
In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on Travere Therapeutics, with a price target of $49.00. Brat......
Travere Therapeutics, Inc. ($TVTX) announced an update on their ongoing clinical study. The phase 3 PROTECT study, officially titled “A Randomized,......
Traders will find the latest stock market stories worth reading in the TIpRanks daily wrap-up. ...
Traders will find the latest stock market stories worth reading in the TIpRanks daily wrap-up. ...
In a report released yesterday, Jason Zemansky from Bank of America Securities reiterated a Buy rating on Travere Therapeutics, with a price target......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TVTX | $40.50 | -0.8% | 1.36M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Travere Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW